Home / Going-concern warnings / Rani Therapeutics Holdings, Inc.
Filed 2025-11-06 路 Form 10-Q 路 Accession 0001193125-25-269774 small
Price before filing: $2.5 (2025-11-05 close, split/dividend-adjusted)
Market cap at flag: $333.9M (2025-11-06) 路 Latest: $119.9M (2026-10-16)
| Window | RANI | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -37.6% | +0.9% | -38.5% | 2025-12-08 |
| 90 days | -52.4% | +1.6% | -54.0% | 2026-02-04 |
| 180 days | -64.6% | +7.4% | -72.1% | 2026-05-05 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 1 insider sold $15.7M (2 sales); 1 insider bought $1.3M (1 purchase)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-10-20 | South Cone Investments Limited Partnership 10% owner | Sale | 1,923,000 | $2.41 | $4.6M | no | Form 4 |
| 2025-10-21 | South Cone Investments Limited Partnership 10% owner | Sale | 4,000,000 | $2.77 | $11.1M | no | Form 4 |
| 2025-10-23 | IMRAN MIR A Director, 10% owner | Purchase | 2,083,334 | $0.60 | $1.3M | no | Form 4 |
| 2025-11-06: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-08-08 to 2025-12-06. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"While t hese factors had raised substantial doubt about our ability to continue as a going concern, after September 30, 2025, as disclosed in more detail in Note 16, the Company entered into various financing agreements and a license and collaboration agreement in October 2025."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-09-30)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.